Quais remédios devemos usar no tratamento do TDAH?
Vejo muitas pessoas usando mais de um remédio para o TDAH, mas será que isso é realmente correto?
Nesse vídeo explico um pouco melhor sobre o assunto, se ainda tiver dúvidas deixe nos comentários.

#tdah #tdahadulto #tdahinfantil #psiquiatria #psiquiatra #risperidona

Seguem as referências dos estudos citados:

Hoekstra, P.J., Dietrich, A. First do no harm: use off-label antipsychotic medication in children and adolescents with great caution. Eur Child Adolesc Psychiatry 31, 1–3 (2022). doi.org/10.1007/s00787-022-01950-7

Pozzi, M., Ferrentino, R.I., Scrinzi, G. et al. Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression. Eur Child Adolesc Psychiatry 31, 21–37 (2022). doi.org/10.1007/s00787-020-01582-9

Man, K.K.C., Shao, SC., Chaiyakunapruk, N. et al. Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: a multinational sequence symmetry study. Eur Child Adolesc Psychiatry 31, 99–120 (2022). doi.org/10.1007/s00787-020-01674-6

Stämpfli, D., Weiler, S. & Burden, A. Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance. Eur Child Adolesc Psychiatry 30, 1047–1058 (2021). doi.org/10.1007/s00787-020-01589-2

Jeon, S.M., Park, S., Kim, D. et al. Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case–control study in Korea. Eur Child Adolesc Psychiatry 30, 391–399 (2021). doi.org/10.1007/s00787-020-01525-4

Dinnissen, M., Dietrich, A., van der Molen, J.H. et al. Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence. Eur Child Adolesc Psychiatry 29, 1717–1727 (2020). doi.org/10.1007/s00787-020-01488-6

Varimo E, Aronen ET, Mogk H, Rättö H, Saastamoinen LK (2021) Antipsychotic treatment duration in children and adolescents: a register-based nationwide study. J Child Adolesc Psychopharmacol 31(6):421–429.  doi.org/10.1089/cap.2020.0095 - DOI 

Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR Jr, Schneider J, Aman MG (2016) Severely aggressive children receiving stimulant medication versus stimulant and risperidone: 12-month follow-up of the TOSCA trial. J Am Acad Child Adolesc Psychiatry 55(6):469–478.  doi.org/10.1016/j.jaac.2016.03.014 

Blader JC, Pliszka SR, Kafantaris V, Foley CA, Carlson GA, Crowell JA, Bailey BY, Sauder C, Daviss WB, Sinha C, Matthews TL, Margulies DM (2021) Stepped treatment for attention-deficit/hyperactivity disorder and aggressive behavior: a randomized, controlled trial of adjunctive risperidone, divalproex sodium, or placebo after stimulant medication optimization. J Am Acad Child Adolesc Psychiatry 60(2):236–251

Nobel E, Hoekstra PJ, Agnes Brunnekreef J, Messink-de Vries DEH, Fischer B, Emmelkamp PMG, van den Hoofdakker BJ (2020) Home-based parent training for school-aged children with attention-deficit/hyperactivity disorder and behavior problems with remaining impairing disruptive behaviors after routine treatment: a randomized controlled trial. Eur Child Adolesc Psychiatry 29(3):395–408.  doi.org/10.1007/s00787-019-01375-9 - DOI 

Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018 Sep;5(9):727-738. doi: 10.1016/S2215-0366(18)30269-4. Epub 2018 Aug 7. PMID: 30097390; PMCID: PMC6109107.

| INSCREVA-SE |
youtube.com/c/JoãoHenriqueDupin

| PUBLICIDADE E PALESTRAS |
contato@jhdupin.com.br

| SIGA-NOS|
• Facebook: facebook.com/Joaohdupin
• Instagram: instagram.com/joaohenriquedupin/

Roteiro e apresentação: João Henrique Dupin
Arte: Bruno Aguirre
Edição: Agência EPK

• Como tratamos o TDAH e qual o papel da risperidona. ( Download)
• A risperidona é frequentemente utilizada para tratar sintomas comportamentais no TEA e TDAH. ( Download)
• Alerta sobre a Risperidona (Risperdal), cuidados e efeitos colaterais [CUIDADO] ( Download)
• É SEGURO USAR RISPERIDONA ( Download)
• TRATAMENTOS PARA TDAH | ANA BEATRIZ ( Download)
• Para que serve o remédio no TDAH infantil Siga para saber mais! ( Download)
• Dr. Rodrigo responde: crianças autistas e o uso de medicação ( Download)
• RISPERIDONA NO TRANSTORNO DESAFIADOR OPOSITIVO ( Download)
• As medicações são seguras para o cérebro com TDAH ( Download)
• Risperidona: Para que serve e efeitos colaterais ( Download)
• RISPERIDONA e ARIPRIPAZOL: Medicação Comum para AUTISMO ( Download)
• Entenda como a RISPERIDONA age no seu CÉREBRO! ( Download)
• RISPERIDONA: PARA QUE SERVE | DR.LABINAS ( Download)
• O que é a Risperidona (Risperdal) e para que serve [Atenção] | Dr. Tontura e Dra. Maria Fernanda ( Download)
• Como Reverter o Autismo e o TDAH - Tratamento Natural e Remédios Caseiros ( Download)